Trump’s executive order to separate combination shots will drive up drugmaker costs; The Supreme Court declined Eli Lilly’s ...

Adam Wyldeck joined AstraZeneca as head of corporate affairs, U.S. Biopharma. Quanterix hired Jim Gute as chief commercial ...

Medical marketing industry leaders explain why networking, transferable skills and hands-on training still matter as AI ...

The era of the vertical video presents plenty of opportunities for pharma brands to message on established and emerging ...

WPP has more than doubled its incentive pool in the first half of 2026 to £130m, up by 120.3% year on year. It follows a 2.8% ...

Rather than hand the naming process to a small executive committee, Ingenyx and Matchstick built a survey and naming portal ...

President Trump signs executive order changing childhood vaccination schedules; Plans are nearly finalized for Luigi Mangione ...

The Detroit Pistons point guard discusses his partnership with Thorne, the difference between an endorsement and an ...

The steady creep of healthcare costs is top of mind not just in Asheville but for most U.S. voters, according to an April KFF poll. Nearly two-thirds of U.S. adults were worried about being able to ...

By registering you consent to the collection and use of your information to provide the products and services you have requested from us and as described in our privacy policy and terms and conditions ...

The FDA approved Moderna’s mRNA-based flu vaccine; Erica Schwartz was confirmed as director of the CDC; Another child died ...

Broadly speaking, the Q2 pharma earnings reports paint a picture of an industry willing to continue to spend where they can boost the topline while also reprioritizing efforts that are less profitable ...